Literature DB >> 235157

Vascular spider: a cutaneous manifestation of hyperdynamic blood flow in hepatic cirrhosis.

C L Witte, T Hicks, W Renert, M H Witte, C Butler.   

Abstract

Arteriography and gas analysis of blood aspirated from a vascular spider in a patient with hepatic cirrhosis were done before excision and histologic examination of the lesion. This study supports earlier work suggesting that a spider angioma is a cutaneous manifestation of a generalized hyperdynamic circulation in hepatic cirrhosis. Moreover, based upon a variety of experimental and clinical observations on the splanchnic circulation in cirrhosis, it is suggested that the portal hypertension blood flow encounters the obstacle posed by the scarred liver ("active congestion").

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235157

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  A necklace of telangiectases: an early clinical sign of alcohol abuse.

Authors:  K R Bashir
Journal:  Can Fam Physician       Date:  1984-10       Impact factor: 3.275

2.  The significance of cutaneous spider naevi in children.

Authors:  S M Finn; M Rowland; F Lawlor; W Kinsella; L Chan; O Byrne; O O'Mahony; B Bourke
Journal:  Arch Dis Child       Date:  2006-04-04       Impact factor: 3.791

3.  An Unusual Case of Hepato-Pulmonary-Cutaneous Syndrome With Giant Spider Angioma and Intracranial Bleed.

Authors:  Shekhar Singh Jadaun; Sanjiv Saigal; Ana Hasnain; Mukesh Kumar; Dhiraj Agrawal; Shweta Singh; Dibyajyoti das; Shaleen Agarwal; Subhash Gupta
Journal:  J Clin Exp Hepatol       Date:  2021-12-30

4.  The circulation in portal hypertension.

Authors:  C L Witte; M H Witte
Journal:  Yale J Biol Med       Date:  1975-05

5.  Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis.

Authors:  Hongyu Li; Ran Wang; Nahum Méndez-Sánchez; Ying Peng; Xiaozhong Guo; Xingshun Qi
Journal:  Arch Med Sci       Date:  2018-03-28       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.